Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer-Reference-Cited by-同舟云学术

Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer

Published:2020-02 Issue:2 Volume:19 Page:245-260
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Alexandrova Elena^ORCID,Giurato Giorgio^ORCID,Saggese Pasquale,Pecoraro Giovanni,Lamberti Jessica,Ravo Maria,Rizzo Francesca^ORCID,Rocco Domenico,Tarallo Roberta,Nyman Tuula A.,Collina Francesca,Cantile Monica,Di Bonito Maurizio,Botti Gerardo,Nassa Giovanni^ORCID,Weisz Alessandro^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference79 articles.

1. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment;Garrido-Castro;Cancer Discov,2019

2. Insufficient antibody validation challenges oestrogen receptor beta research;Andersson;Nat. Commun,2017

3. Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity;Nelson;Mol. Cell. Endocrinol,2017

4. Estrogen receptors in breast carcinogenesis and endocrine therapy;Huang;Mol. Cell. Endocrinol,2015

5. Estrogen receptor β as a pharmaceutical target;Warner;Trends Pharmacol. Sci,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesteryl ester transfer protein knock‐down in conjunction with a cholesterol‐depleting agent decreases tamoxifen resistance in breast cancer cells;IUBMB Life;2024-05-11

2. Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor;Receptors;2024-05-03

3. Therapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention;RNA Biology;2023-12-13

4. Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research;Frontiers in Cell and Developmental Biology;2023-10-23

5. Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression;Pharmacology & Therapeutics;2023-02